BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8793481)

  • 21. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
    Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
    Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cell with a thousand faces: detection of myoepithelial cells and their contributions in the cytological diagnosis of salivary gland tumors.
    Avci A; Günhan O; Cakalağaoğlu F; Günal A; Celasun B
    Diagn Cytopathol; 2012 Mar; 40(3):220-7. PubMed ID: 20891000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
    Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
    J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraoral minor salivary gland neoplasms: review of 213 cases.
    Yih WY; Kratochvil FJ; Stewart JC
    J Oral Maxillofac Surg; 2005 Jun; 63(6):805-10. PubMed ID: 15944978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of DNA content in salivary gland tumors].
    Yáñez M; Roa I; Villaseca M; Fuentealba P
    Rev Med Chil; 1997 Oct; 125(10):1177-81. PubMed ID: 9609036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT3 expression in salivary gland tumours.
    de Araújo VC; Furuse C; Cury PR; Altemani A; de Araújo NS
    Oral Oncol; 2008 May; 44(5):439-45. PubMed ID: 17826306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary gland tumors in children and adolescents: a clinicopathologic and immunohistochemical study of fifty-three cases.
    da Cruz Perez DE; Pires FR; Alves FA; Almeida OP; Kowalski LP
    Int J Pediatr Otorhinolaryngol; 2004 Jul; 68(7):895-902. PubMed ID: 15183580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative frequency of intra-oral minor salivary gland tumors: a study of 380 cases from northern California and comparison to reports from other parts of the world.
    Buchner A; Merrell PW; Carpenter WM
    J Oral Pathol Med; 2007 Apr; 36(4):207-14. PubMed ID: 17391298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
    Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
    Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary gland Basal cell adenomas--immunohistochemical evaluation of four cases and review of the literature.
    Mărgăritescu C; Mercuţ V; Mogoantă L; Florescu M; Simionescu C; Cionca L; Manea M
    Rom J Morphol Embryol; 2005; 46(1):29-40. PubMed ID: 16286982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
    Lewis JE; Olsen KD; Sebo TJ
    Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical relevance of ploidy and S-phase fraction determination in salivary gland tumors: a flow cytometric study of 97 cases.
    Pinto AE; Fonseca I; Soares J
    Cancer; 1999 Jan; 85(2):273-81. PubMed ID: 10023692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric DNA ploidy in salivary gland tumours.
    Driemel O; Maier H; Kraft K; Haase S; Hemmer J
    Oncol Rep; 2005 Jan; 13(1):161-5. PubMed ID: 15583819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor markers in parotid gland carcinomas: immunohistochemical investigations.
    Seifert G; Caselitz J
    Cancer Detect Prev; 1983; 6(1-2):119-30. PubMed ID: 6192916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-6 Integrin, tenascin-C, and MMP-1 expression in salivary gland neoplasms.
    Westernoff TH; Jordan RC; Regezi JA; Ramos DM; Schmidt BL
    Oral Oncol; 2005 Feb; 41(2):170-4. PubMed ID: 15695119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-catenin and E-cadherin expression in salivary gland tumors.
    Furuse C; Cury PR; Altemani A; dos Santos Pinto D; de Araújo NS; de Araújo VC
    Int J Surg Pathol; 2006 Jul; 14(3):212-7. PubMed ID: 16959701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression of cell cycle regulators p21, p27, and p53 in tumors of salivary glands and paranasal sinuses.
    Affolter A; Helmbrecht S; Finger S; Hörmann K; Götte K
    Oncol Rep; 2005 Jun; 13(6):1089-94. PubMed ID: 15870926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
    Monteiro LS; Bento MJ; Palmeira C; Lopes C
    J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
    Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into a complex group of neoplastic disease: advances in histopathologic classification and molecular pathology of salivary gland cancer.
    Leivo I
    Acta Oncol; 2006; 45(6):662-8. PubMed ID: 16938808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.